Cargando…

Multigene profiles to guide the use of neoadjuvant chemotherapy for breast cancer: a Copenhagen Breast Cancer Genomics Study

Estrogen receptor (ER) and human epidermal growth factor 2 (HER2) expression guide the use of neoadjuvant chemotherapy (NACT) in patients with early breast cancer. We evaluate the independent predictive value of adding a multigene profile (CIT256 and PAM50) to immunohistochemical (IHC) profile regar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensen, M.-B., Pedersen, C. B., Misiakou, M.-A., Talman, M.-L. M., Gibson, L., Tange, U. B., Kledal, H., Vejborg, I., Kroman, N., Nielsen, F. C., Ejlertsen, B., Rossing, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232408/ https://www.ncbi.nlm.nih.gov/pubmed/37258527 http://dx.doi.org/10.1038/s41523-023-00551-0

Ejemplares similares

Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status
por: Rossing, Maria, et al.
Publicado: (2021)

Impact of invitation schemes on breast cancer screening coverage: A cohort study from Copenhagen, Denmark
por: Jacobsen, Katja Kemp, et al.
Publicado: (2016)

Whole genome sequencing of breast cancer
por: Rossing, Maria, et al.
Publicado: (2019)

Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients
por: Freeman, Jincong Q., et al.
Publicado: (2023)

Emergence of linezolid-resistant Enterococcus faecium in a tertiary hospital in Copenhagen
por: Misiakou, Maria-Anna, et al.
Publicado: (2023)

Outcome of breast cancer screening in Denmark
por: Lynge, Elsebeth, et al.
Publicado: (2017)

Multigene tests for breast cancer: the physician’s perspective
por: Cognetti, Francesco, et al.
Publicado: (2021)

A catalog of curated breast cancer genes
por: Bose, Muthiah, et al.
Publicado: (2021)

Clinical outcomes based on multigene profiling in metastatic breast cancer patients
por: Basho, Reva K., et al.
Publicado: (2016)

Strain histograms are equal to strain ratios in predicting malignancy in breast tumours
por: Carlsen, Jonathan Frederik, et al.
Publicado: (2017)

Breast density and risk of breast cancer
por: Lynge, Elsebeth, et al.
Publicado: (2022)

PROCURE European consensus on breast cancer multigene signatures in early breast cancer management
por: Curigliano, Giuseppe, et al.
Publicado: (2023)

The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study
por: Bens, Annet, et al.
Publicado: (2020)

Multigene prognostic tests in breast cancer: past, present, future
por: Győrffy, Balázs, et al.
Publicado: (2015)

The Role of Multigene Assays in Addressing Treatment Heterogeneity for Breast Cancer
por: Aapro, Matti
Publicado: (2017)

The Social Distribution of Cancer in Copenhagen, 1943 to 1947
por: Clemmesen, J., et al.
Publicado: (1951)

Predictive value of DNA repair gene expression for response to neoadjuvant chemotherapy in breast cancer
por: Kneubil, M.C., et al.
Publicado: (2022)

Evaluating the Effectiveness of Neoadjuvant Chemotherapy in Reducing Mastectomy for Women With Breast Cancer
por: Mohiuddin, Jahan J., et al.
Publicado: (2017)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study
por: Buhl, Anna Sofie Kappel, et al.
Publicado: (2018)

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
por: Shimelis, Hermela, et al.
Publicado: (2018)

Neoadjuvant systemic therapy for breast cancer
por: Zaborowski, Alexandra M, et al.
Publicado: (2023)

Breast cancer recurrence after reoperation for surgical bleeding
por: Pedersen, R N, et al.
Publicado: (2017)

A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
por: Sun, Li, et al.
Publicado: (2019)

Targeted Axillary Dissection with (125)I Seed Placement Before Neoadjuvant Chemotherapy in a Danish Multicenter Cohort
por: Munck, Frederikke, et al.
Publicado: (2023)

An Update on Breast Cancer Multigene Prognostic Tests—Emergent Clinical Biomarkers
por: Vieira, André Filipe, et al.
Publicado: (2018)

Tumor microenvironment-related multigene prognostic prediction model for breast cancer
por: Hong, Kai, et al.
Publicado: (2022)

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER(+), HER2(−) early breast cancer
por: Exner, R, et al.
Publicado: (2014)

Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?
por: Warren, R M L, et al.
Publicado: (2004)

Stage of breast cancer at diagnosis among women with cosmetic breast implants
por: Hölmich, L R, et al.
Publicado: (2003)

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
por: Solin, Lawrence J., et al.
Publicado: (2013)

Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action.
por: Kamby, C., et al.
Publicado: (1988)

Breast cancer survival and season of surgery: an ecological open cohort study
por: Teilum, Dorthe, et al.
Publicado: (2012)

The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
por: Asphaug, Lars, et al.
Publicado: (2019)

Should a Multigene Signature be Used in all Luminal Early Breast Cancers
por: Hajjaji, Nawale, et al.
Publicado: (2019)

Predictive Factors of Response in HER2-Positive Breast Cancer Treated by Neoadjuvant Therapy
por: Guiu, S., et al.
Publicado: (2013)

Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands
por: Heeg, E., et al.
Publicado: (2020)

Parity, age at first childbirth and the prognosis of primary breast cancer.
por: Kroman, N., et al.
Publicado: (1998)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
por: Straver, M. E., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fft1nmocorgv10i6l0idgdihik